Search

Travere Therapeutics Inc

Lezárt

62.1 1.37

Áttekintés

Árfolyamváltozás megosztása

24 óra

Jelenlegi

Minimum

60.06

Maximum

62.42

Fő mutatók

By Trading Economics

Bevétel

1.3M

-35M

Értékesítés

42M

170M

Egy részvényre jutó nyereség

-0.37

Profit margin

-20.814

Munkavállalók

497

EBITDA

-24M

-33M

Ajánlások

By TipRanks

Ajánlások

Erős vétel

12 hónapos előrejelzés

+18.96% upside

Osztalékok

By Acuity

Következő eredményjelentés

2026. okt. 29.

Piaci statisztika

By TradingEconomics

Piaci kapitalizáció

627M

5.7B

Előző nyitás

60.73

Előző zárás

62.1

Travere Therapeutics Inc Chart

A múltbeli teljesítmény nem megbízható mutatója a jövőbeli eredményeknek.

Kapcsolódó hírek

2026. aug. 14. 23:56 UTC

Columbia Banking System Inc shares are higher in after-market trading, maintaining an upward trend since Friday's close, with no specific news identified for the movement.

2026. aug. 14. 23:56 UTC

Lowe's Companies Inc saw modest gains during after-market hours, trading near the upper end of its one-month range and above its 20-day moving average.

2026. aug. 14. 23:56 UTC

CEVA Inc shares are higher in after-market trading, reaching a session high earlier. The stock remains within its one-month trading range.

2026. aug. 14. 23:56 UTC

Whirlpool Corp shares are trading lower in after-market hours. No specific news was identified to explain the movement.

2026. aug. 14. 23:56 UTC

ETF Constituents

Vanguard FTSE Developed Markets ETF rises in after-market trading, supported by strong performances from top holdings including UL, KB, SAP, FLUT, and CVE.

2026. aug. 14. 23:56 UTC

Ardelyx Inc. shares declined in after-market trading, continuing a broader trend of significant decline over the past month, remaining below the 20-day moving average.

2026. aug. 14. 23:56 UTC

Aptiv PLC shares are trading higher in after-market hours following an early spike, amid a market characterized by complacency and stable equities.

2026. aug. 14. 23:56 UTC

Fox Corp shares are lower in after-market hours, showing unusual volatility. No specific news was identified to explain the movement.

2026. aug. 14. 23:56 UTC

Encore Capital Group Inc shares are higher in after-market trading, continuing a positive trend following four consecutive sessions of gains. No specific news was identified.

2026. aug. 14. 23:56 UTC

Commercial Metals Co. shares declined after-market, continuing a trend of three consecutive lower daily closes, despite remaining above the 20-day moving average.

2026. aug. 14. 23:56 UTC

ETF Constituents

The Consumer Staples Select Sector SPDR Fund is trading higher in after-market hours, supported by gains from top holdings like Monster Beverage and Walmart.

2026. aug. 14. 23:56 UTC

Macro News
ETF Constituents

VanEck Gold Miners ETF rises in after-market trading amid U.S.-Iran tensions and a weaker U.S. Dollar Index, boosting demand for safe-haven assets.

2026. aug. 14. 23:56 UTC

Cognizant Technology Solutions shares are higher in after-market trading, recovering from earlier losses amid a mixed backdrop in global equity markets.

2026. aug. 14. 23:52 UTC

News

Boeing Co secures over $711 million in U.S. defense contract modifications, boosting investor sentiment. Shares are higher in after-market trading.

2026. aug. 14. 23:51 UTC

Insight Enterprises Inc. shares are trading slightly lower after-market, amid broader market concerns following a surprising decline in U.S. retail sales for July.

2026. aug. 14. 23:51 UTC

Turning Point Brands Inc shares are higher in after-market hours, trading above their 20-day moving average amid broader market concerns over declining U.S. retail sales.

2026. aug. 14. 23:51 UTC

ETF Constituents

Energy Select Sector SPDR Fund rose in after-market hours, driven by gains from Valero Energy, Chevron, and Exxon Mobil, offsetting minor declines from Marathon and Occidental.

2026. aug. 14. 23:51 UTC

Vipshop Holdings Ltd shares are higher in after-market hours, diverging from recent declines despite a drop in U.S. retail sales for July.

2026. aug. 14. 23:51 UTC

Kanzhun Ltd. shares are lower in after-market hours, reflecting a decline following disappointing U.S. retail sales data and shifting market sentiment on interest rates.

2026. aug. 14. 23:51 UTC

Cognex Corp shares are lower in after-market hours amid broader market concerns following a decline in U.S. retail sales for July.

2026. aug. 14. 23:51 UTC

Abercrombie & Fitch Co shares are lower in after-market hours following a decline in U.S. retail sales for July, raising concerns about consumer spending.

2026. aug. 14. 23:51 UTC

RingCentral Inc. shares are higher in after-market trading, reflecting positive momentum following Friday's close, despite concerns over July's U.S. retail sales decline.

2026. aug. 14. 23:51 UTC

Social Media

Moderna shares are lower in after-market hours amid concerns over the FDA's approval of its mRNA flu vaccine and modest trial data effectiveness.

2026. aug. 14. 23:51 UTC

Tower Semiconductor shares are higher in after-market trading, remaining above their 20-day moving average despite a decline in U.S. retail sales for July.

2026. aug. 14. 23:51 UTC

Karyopharm Therapeutics shares are higher in after-market trading, despite no specific news. Broader market sentiment reflects concerns from a decline in U.S. retail sales.

2026. aug. 14. 23:51 UTC

News

PayPal is in advanced talks for a potential sale to Stripe and Advent, following a proposal of $60.50 per share. Shares are higher in after-market trading.

2026. aug. 14. 23:51 UTC

China's House Price Index YoY release on August 17, 2026, signals cautious market sentiment amid ongoing housing challenges and weak demand.

2026. aug. 14. 23:51 UTC

Social Media

BJ's Wholesale Club Holdings Inc. is trading higher in after-market hours following its scheduled earnings report amid positive market sentiment despite a drop in U.S. retail sales.

2026. aug. 14. 23:51 UTC

Griffon Corp shares are lower in after-market hours amid weak market sentiment and disappointing U.S. retail sales data, which diverged from expectations.

2026. aug. 14. 23:51 UTC

In after-market trading, Bloomin' Brands Inc is moving higher, reflecting strong performance despite a decline in U.S. retail sales for July.

Társak összehasonlítása

Árváltozás

Travere Therapeutics Inc Előrejelzés

Célár

By TipRanks

18.96% elmozdulás felfelé

12 hónapos előrejelzés

Átlag 73.08 USD  18.96%

Magas 90 USD

Alacsony 49 USD

12 Wall Street elemző 12 hónapos célárain alapulva a(z)Travere Therapeutics Inc termékhez az elmúlt 3 hónapban.

Értékelési konszenzus

By TipRanks

Erős vétel

12 ratings

11

Vétel

1

Tartás

0

Eladás

Pénzügyek

Értékesítési és adminisztrációs költségek

Üzemeltetési költségek

Adózás előtti nyereség

Értékesítés

Értékesítési költség

Értékesítési bruttó nyereség

Kamatköltség a hitelre

EBITDA

Üzemi nyereség

$

Rólunk Travere Therapeutics Inc

Travere Therapeutics, Inc., a biopharmaceutical company, identifies, develops, and delivers therapies to people living with rare kidney and metabolic diseases. Its products include FILSPARI (sparsentan), a once-daily, oral medication designed to target two critical pathways in the disease progression of IgA Nephropathy (endothelin 1 and angiotensin-II); and Thiola and Thiola EC (tiopronin tablets) for the treatment of cystinuria, a rare genetic cystine transport disorder that causes high cystine levels in the urine and the formation of recurring kidney stones. The company's clinical-stage programs consist of Sparsentan, a novel investigational product candidate, which has been granted Orphan Drug Designation for the treatment of focal segmental glomerulosclerosis in the U.S. and Europe; and Pegtibatinase (TVT-058), a novel investigational human enzyme replacement candidate being evaluated for the treatment of classical homocystinuria. It has a cooperative research and development agreement with National Institutes of Health's National Center for Advancing Translational Sciences and Alagille Syndrome Alliance for the identification of potential small molecule therapeutics for Alagille syndrome. The company was formerly known as Retrophin, Inc. and changed its name to Travere Therapeutics, Inc. in November 2020. Travere Therapeutics, Inc. was incorporated in 2008 and is headquartered in San Diego, California.
help-icon Live chat